Prognostic factors for conversion to generalization in ocular myasthenia gravis.

Medicine
Juthamat WitthayaweerasakNipat Aui-Aree

Abstract

Patients with ocular myasthenia gravis (OMG) are frequently treated to prevent the development of generalized myasthenia gravis (GMG). This retrospective cohort study aimed to assess prognostic factors associated with conversion to GMG.We analyzed the time from the onset of OMG symptoms to GMG in relation to demographic variables, clinical findings, initial investigation results, and treatment regimens using Kaplan-Meier survival curves and multivariate Cox proportional regression analysis.Of 115 patients diagnosed with OMG (median follow-up time, 2.9 years), 28 (30.4%) developed GMG. The 2-year probability of GMG conversion was 23.7%. Patients with thymic abnormalities and a positive response to repetitive facial nerve stimulation had a significantly higher risk than those with negative results (hazard ratios [HR] 4.28, P < .001 and HR 3.84, P = .04, respectively). Treatment with immunosuppressants was found to be a preventive factor for secondary generalization (HR 0.36, P = .02).Patients with OMG had a low risk of developing GMG. Immunosuppressive treatments may mitigate disease progression. Chest imaging and repetitive nerve stimulation should be routinely performed to assess the risk of generalization.

References

Dec 1, 1985·Journal of Neurology, Neurosurgery, and Psychiatry·A Vincent, J Newsom-Davis
Nov 1, 1983·Annals of Neurology·C T BeverL P Rowland
Aug 1, 1996·Archives of Neurology·M J KupersmithH Weinberg
Feb 1, 1997·Journal of Neurology, Neurosurgery, and Psychiatry·N SommerJ Dichgans
Jul 16, 1999·Ophthalmology·K C GolnikE R Eggenberger
Jul 6, 2000·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·L PaduaP Tonali
Feb 13, 2003·Archives of Neurology·Mark J KupersmithPeter Homel
Jul 23, 2003·Muscle & Nerve·Erik H NiksJ Gert Van Dijk
Dec 10, 2003·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Jared MeeJustin O'Day
Jan 7, 2004·Journal of the Neurological Sciences·Nicholas T MonsulJonathan M Goldstein
Nov 18, 2004·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·João CostaMamede de Carvalho
Dec 7, 2007·Muscle & Nerve·David GrobMurali Pagala
Jul 8, 2008·Journal of the Neurological Sciences·Yoon-Ho HongUNKNOWN Korean Research Group for Neuromuscular Diseases
Oct 16, 2008·Current Opinion in Ophthalmology·Aileen A Antonio-Santos, Eric R Eggenberger
Mar 1, 2005·Journal of Clinical Neuromuscular Disease·Hans D Katzberg, Vera Bril
Sep 12, 2009·Ophthalmology·Klio I ChatzistefanouMichael Apostolopoulos
Nov 18, 2009·Muscle & Nerve·Jeffrey A AllenH Royden Jones
Mar 1, 2012·Journal of Clinical Neuromuscular Disease·Manoj Kumar MittalMazen Dimachkie
Nov 26, 2013·Current Neurology and Neuroscience Reports·Sui H WongGordon T Plant
Apr 22, 2015·Ophthalmology·Lina NagiaEric R Eggenberger
Jul 17, 2015·Muscle & Nerve·Michael BenatarUNKNOWN Muscle Study Group (MSG)
Aug 11, 2015·JAMA Neurology·Crandall E PeelerWayne T Cornblath
Sep 18, 2015·Lancet Neurology·Nils Erik Gilhus, Jan J Verschuuren
Apr 1, 2016·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Sui H WongGordon T Plant
Jun 20, 2017·The International Journal of Neuroscience·Marco MazzoliGiuliana Galassi
Sep 8, 2017·Muscle & Nerve·Sivesh K KamarajahArulmaran Sivaguru
Oct 6, 2017·Muscle & Nerve·Kelvin Y TeoDan Milea
Feb 13, 2018·European Neurology·Florencia Aguirre, Andres M Villa
Sep 19, 2018·Journal of Neurology·Feng LiJens-C Rückert
May 12, 2019·American Journal of Ophthalmology·Tina M HendricksJohn J Chen
Sep 29, 2019·American Journal of Ophthalmology·Supanut ApinyawasisukSupharat Jariyakosol

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.